Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases.

Translated title of the contribution: Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases.

M. de Boer, E.M. Adang, K.C.G. van Dycke, JAAM van Dijck, G.F. Borm, S.C. Seferina, C.H.M. van Deurzen, P.J. van Diest, P. Bult, A.R.T. Donders, V.C.G. Tjan-Heijnen

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionCost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases.
Original languageUndefined/Unknown
Pages (from-to)2585-2591
Number of pages7
JournalAnnals of Oncology
Volume23
Issue number10
Publication statusPublished - 2012

Cite this